Health & Fitness
Health and Fitness
Health and Fitness
Sat, June 5, 2010
Fri, June 4, 2010
Thu, June 3, 2010 Celldex Therapeutics to Present at Upcoming Investor Conferences in New York City
NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the following investor conferences:
- Jefferies 2010 Global Life Sciences Conference on Tuesday, June 8, 2010 at 3:00 pm ET
- 9th Annual Needham Healthcare Conference on Wednesday, June 9, 2010 at 9:20 am ET
A live webcast of the audio and slide presentation from the Jefferies event will be available online on the aPresentationsa page of the aInvestorsa section of the Celldex website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].
